Endogenous interleukin-11 (IL-11) expression is increased and prophylactic use of exogenous IL-11 enhances platelet recovery and improves survival during thrombocytopenia associated with experimental group B streptococcal sepsis in neonatal rats

Blood Cells, Molecules, and Diseases

Volumn 22, Issue 1, 1996, Pages 57-67

  Chang, Mei ^a   Williams, Angela ^a   Ishizawa, Lori ^a   Knoppel, Annika ^a   Van De Ven, Carmella ^a   Cairo, Mitchell S ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

IL 11; mRNA; Neonatal rats; Sepsis; Thrombocytopenia

Indexed keywords

HUMAN SERUM ALBUMIN; INTERLEUKIN 11; MESSENGER RNA; RECOMBINANT INTERLEUKIN 11; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0030130895     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1996.0009     Document Type: Article

References (33)

1. 1. Cairo M, Worcester C, Rucker R, et al. Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis. J Pediatr 110(6):935-941, 1987.
2. 2. Cairo M. Neonatal neutrophil host defense. Am J Dis Child 143:40-46, 1989.
3. 3. Christensen R, Shigeoka A, Hill H, Rothstein G. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis. Pediatr Res 14:806-808, 1980.
4. 4. Christensen R, Rothstein G. Pre and post-natal development of granulocyte stem cells (CFUc) in the rat. Pediatr Res 18:599-602, 1984.
5. 5. Erdman S, Christensen R, Bradley P, Rothstein G. Supply and release of storage neutrophils: A developmental study. Biol Neonate 41:132-137, 1982.
6. 6. Siegel J, McCracken G. Sepsis neonatorum. N Engl J Med 304:642-647, 1981.
7. 7. Ferrieri P. An overview of neonatal sepsis and the limitations of antimicrobial therapy. In: Session 1 pathogens and current treatment of infections in the newborn. Immunopathology Immunotherapy Forum Suppl 1:2, 1988.
8. 8. Nathan D. Regulation of hematopoiesis. Pediatr Res 27:423-431, 1990.
9. 9. Du X, Williams D. Interleukin-11: A multifunctional growth factor derived from the hematopoietic microenvironment. Blood 83:2023-2030, 1994.
10. 10. Neben S, Turner K. The biology of interleukin 11. Stem Cells 11 (suppl 2):156-162, 1993.
11. 11. Paul S, Schendel P. The cloning and biological characterization of recombinant human interleukin 11. Int J Cell Cloning 10:135-143, 1992.
12. 12. Musashi M, Yang Y, Paul S, Clark S, Sudo T, Ogawa M. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc Natl Acad Sci USA 88:765-769, 1991.
13. 13. Van de Ven C, Law P, Ishizawa L, et al. IL-11 in combination with Steel factor (SLF) significantly increases CFU-MEG & CFU-GM formation from isolated CD34+ cord blood compared to adult bone marrow: Implications in ex vivo expansion of cord blood. Exp Hematol In press 1995.
14. 14. Cairo M, Plunkett J, Nguyen A, Schendel P, van de Ven C. Effect of Interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: Induction of neonatal thrombocytosis by Interleukin-11 and synergistic enhancement of neutrophilia by Interleukin-11 + granulocyte colony-stimulating factor. Pediatr Res 34:56-61, 1993.
15. 15. Cairo M, Plunkett J, Schendel P, van de Ven C. The combined effects of Interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count. Exp Hematol 22:1118-1123, 1994
16. 16. Yonemura Y, Kawakita M, Masuda T, Fujimoto K, Takatsuki K. Effect of recombinant human interleukin-11 on rat megakaryopoiesis and thrombopoiesis in vivo comparative study with interleukin-6. Br J Haematol 84:16-23, 1993.
17. 17. Neben T, Leobelenz J, Hayes L, et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 81:901-908, 1993.
18. 18. Leonard J, Quinto C, Kozitza M, Neben T, Goldman S. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 83:1499-1506, 1994.
19. 19. Hangoc G, Yin T, Cooper S, Schendel P, Yang Y, Broxmeyer H. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 81:965-972, 1993.
20. 20. Du X, Neben T, Goldman S, Williams D. Effects of recombinant human IL-11 on hematopoietic reconstitution in transplanted mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81:21-34, 1993.
21. 21. Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73:117-122, 1989.
22. 22. Pietsch T, Buhrer C, Mempel K, et al. Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factor. Blood 77:1234-1237, 1991.
23. 23. Kawakami M, Tsutsumi H, Kumakawa T, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76:1962-1964, 1990.
24. 24. Cairo M, Suen Y, Sender L, et al. Circulating granulocyte colony-stimulating factor (G-CSF) levels after allogeneic and autologous bone marrow transplantation: Endogenous G-CSF production correlates with myeloid engraftment. Blood 79:1869-1873, 1992.
25. 25. Cairo M, Gillan E, Weinthal J, et al. Decreased endogenous circulating Steel factor levels following allogeneic and autologous bone marrow transplantation: Lack of an inverse correlation with post-BMT myeloid engraftment. Bone Marrow Transplant 11:155-161, 1993.
26. 26. Suen Y, Nugent D, Chang M, Shen V, Cairo M. Increased IL-11 protein production from activated neonatal vs. adult fibroblasts: its role in the regulation of thrombopoiesis in adults, neonates, and immune thrombocytopenic purpura (ITP) patients. Pediatr Res (abstract)35:171a, 1994.
27. 27. Cairo M, Mauss D, Kommareddy S, Norris K, van de Ven C, Modanlou H. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res 27:612-616, 1990.
28. 28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
29. 29. Singer-Sam J, Robinson M, Bellvé A, Simon M, Riggs A. Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis. Nucleic Acids Res 18:1255-1259, 1990.
30. 30. Suen Y, Chang M, Lee S, Buzby JS, Cairo MS. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84:4125-4134, 1994.
31. 31. Yin T, Schendel P, Yang Y. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J Exp Med 175:211-216, 1992.
32. 32. Du X, Doerschuk C, Orazi A, Williams D. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33-37, 1994.
33. 33. Opal SM, Keith JC, Schaub RG, et al. Beneficial effects of recombinant human interleukin-11 (rhIL-11) in an experimental model of gram-negative sepsis in neutropenic animals. Blood (abstract):498a, 1995.